# Tango Therapeutics, Inc.: Form SC 13D/A, filed Sep 4, 2024

- Company: [Tango Therapeutics, Inc.](/companies/tngx.md) (CIK 1819133)
- Form: SC 13D/A
- Filed: 2024-09-04
- Accepted by EDGAR: Sep 4, 2024, 20:45 ET
- Period: not reported
- Accession: 0001193125-24-213369
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1819133/000119312524213369/d857596dsc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1819133/000119312524213369/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1819133/000119312524213369/d857596dsc13da.htm

Filed Sep 4, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-213369. Last ingested by Listed: Nov 15, 2026, 01:16 ET. No prices; not investment advice.
